Favorable Trend of Implantable Cardioverter‐Defibrillator Service Life in a Large Single‐Nation Population: Insights From 10‐Year Analysis of the Italian Implantable Cardioverter‐Defibrillator Registry. Issue 15 (6th August 2019)

• Record Type: Journal Article
• Authors: Poli, Stefano; Boriani, Giuseppe; Zecchin, Massimo; Facchin, Domenico; Gasparini, Maurizio; Landolina, Maurizio; Ricci, Renato Pietro; Lanera, Corrado; Gregori, Dario; Proclemer, Alessandro
• Is Part Of: Journal of the American Heart Association. Volume 8:Issue 15(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-08-06
• Subjects: implantable cardioverter‐defibrillator -- longevity -- registry; Heart -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Cerebrovascular disease -- Periodicals; Cardiology -- Periodicals; 616.1
• DOI: 10.1161/JAHA.119.012759
• Languages: English
• ISSNs: 2047-9980

Abstract

Abstract : Background: Implantable cardioverter‐defibrillators (ICDs) are widely employed for the prevention of sudden cardiac death. Despite technological improvements, patients often need to undergo generator replacement, which entails the risk of periprocedural complications. Our aim was to estimate the service life of ICDs over a 10‐year interval and to assess the main causes of replacement on the basis of data from the National ICD Registry of the Italian Society of Arrhythmology and Cardiac Pacing (AIAC). Methods and Results: The registry includes data from over 400 hospitals in Italy. We included all patients who underwent device replacement from calendar years 2007 to 2016. The median service life of the ICDs and its trend over the years was estimated across the 3 types of devices (single‐chamber, dual‐chamber, cardiac resynchronization therapy defibrillator) and the indication to implantation. The causes of replacement were also analyzed. We included 29 158 records from 27 676 patients (80.9% men; mean age at device replacement 65.8±12.0 years). The median service life was 57.3 months (interquartile range 27.8 months). Over the years, service life showed an increasing trend. The majority of patients underwent elective replacement because of battery end of life, and over the years there was a significant reduction of replacement for recalls, erosion/infections, and cardiac resynchronization therapy upgrading. Conclusions: Our data from a large single‐nation population showed that the trend of ICD service life, independently from ICD type, indication, and settings, significantly improved over time. Moreover, there was a striking reduction of interventions for upgrading and infection/erosion. This favorable trend has important clinical, organizational, and financial implications.